Zhu Chuanda, Diao Zhenli, Yang Yuanyuan, Liao Jun, Wang Chao, Li Yanglonghao, Liang Zichao, Xu Pengcheng, Liu Xinyu, Zhang Qiang, Gong Lidong, Ma Qiang, Liang Ling, Lin Zhiqiang
School of Basic Medical Sciences, Peking University Health Science Center, Beijing, 100191, China.
Department of Clinical Laboratory, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, 100043, China.
J Nanobiotechnology. 2025 Mar 9;23(1):193. doi: 10.1186/s12951-025-03249-6.
Despite the availability of a series of classical antibiotic drugs, bacterial infections continue to represent a significant and urgent threat to global human health. The emergence of drug-resistant bacteria and the slow pace of antibiotic development have rendered current treatment methods inadequate in meeting the clinical demands of bacterial infections. Consequently, there is an increasingly urgent and vital need for the development of safe, efficient, and alternative novel antimicrobial agents in the medical and healthcare field. Over the past five years, there has been a notable expansion in the field of nanomedicine with regard to the prevention and control of infectious diseases. The objective of this article is to provide a comprehensive review of the latest research developments in the field of metal nanomaterials for medical antimicrobial therapy. We begin by delineating the gravity of the bacterial infection crisis, subsequently undertaking a comprehensive examination of the potential mechanisms through which nanoparticles may combat bacterial infections and the specific applications of these nanomaterials in the treatment of diverse infectious diseases. In conclusion, we eagerly anticipate the future development directions of metal nanomaterials in the field of antimicrobial therapy. We believe that with continuous technological advancements and innovations, this field will make even more outstanding contributions to safeguarding human health and well-being.
Int J Nanomedicine. 2017-11-10
Nanoscale. 2013-9-21
Chem Soc Rev. 2019-1-21
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2024
Expert Rev Anti Infect Ther. 2011-11
Research (Wash D C). 2025-8-21
Beilstein J Nanotechnol. 2025-8-15
JAMA Netw Open. 2024-12-2
Int J Mol Sci. 2024-11-15